Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NV1020 in Colorectal Cancer Metastatic to the Liver
NCT00149396Phase 2Completed
- Sponsor
- Medigene AG
- Start
- Jul 2004
- Primary completion
- Oct 2008
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of NV1020 in colorectal cancer (CRC), sponsored by Medigene AG. Started Jul 2004; status: completed.
02
Drugs
NV1020
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00149396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149396.